Direct nose-to-brain delivery of diazepam via trigeminal nerve contributes to rapid seizure suppression in pentylenetetrazole-induced status epilepticus model rats
Abstract
The purpose of our present study was to elucidate the involvement of the direct transfer to the brain after intranasal (i.n.) administration of diazepam (DZP), and to provide findings whether i.n. the administration could be used to obtain rapid onset of pharmacological action. We determined the blood and brain kinetics of DZP after administrations of i.n. and other routes, and the relationship between their concentrations and rapid seizure suppression effect; furthermore, and evaluated the distribution process of DZP to the brain. There was a negative connection between the plasma concentration and the amount of DZP delivery to the brain from the systemic circulation during the period that followed intravenous and intrarectal injection before the onset of seizure suppression. I.n. administration resulted in the seizure suppression time below the correlation curve: the seizure suppression effects were observed earlier than estimated despite the low plasma concentrations of DZP, suggesting the involvement of direct nose-to-brain delivery of DZP. The time to maximum concentration (Tmax) in the forebrain, hindbrain, olfactory bulb (OB), trigeminal nerve (TN), and cerebrospinal fluid (CSF) after i.n. the administration was 3 min, which was shorter than the Tmax of the plasma concentration. In fluorescence imaging using Rhodamin-B-base, the TN and the area of the vicinity of the thalamus had stronger fluorescence 1 and 3 min after i.n. administration, compared with the OB and CSF. In summary, direct brain delivery of DZP requires the TN and it was suggested that distribution to the vicinity of the thalamus via the TN may be connected to the quick seizure suppression effect.
Keywords: Status Epilepticus, Diazepam, Intranasal Administration, Nose-to-Brain, Trigeminal Nerve
Downloads
References
2) Shery RH, Syndi S, John P. "Benzodiazepine use in seizure emergencies: A systematic review" Epilepsy Behav. 2016; 63:109-17. https://doi.org/10.1016/j.yebeh.2016.07.018
3) Shavonne LM, Hannah CG, Renée AS, Sonia B, Taeun C, Catherine C et al., "Characteristics of neonates with cardiopulmonary disease who experience seizures: A multicenter study" J Pediatr. 2022; 242:67-73. https://doi.org/10.1016/j.jpeds.2021.10.058
4) Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A et al., "Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes" Epilepsia. 2019; 60(1):53-62. https://doi.org/10.1111/epi.14607
5) Bhalla D, Tchalla AE, Mignard C, Marin B, Mignard D, Jallon P et al., "First-ever population-based study on status epilepticus in French Island of la Reunion (France) - incidence and fatality. Seizure" 2014; 23(9):769-73. https://doi.org/10.1016/j.seizure.2014.06.009
6) Cheung TO, Shew MS, Ching FT, Yi SW, Solomon CCC, "Age-dependent sex difference of the incidence and mortality of status epilepticus: A twelve year nationwide population-based cohort study in Taiwan" PLOS ONE. 2015;10. https://doi.org/10.1371/journal.pone.0122350
7) Govoni V, Fallica E, Monetti VC, Guerzoni F, Faggioli R, Casetta I et al., "Incidence of status epilepticus in southern Europe: a population study in the health district of Ferrara, Italy" Eur Neurol. 2008; 59(3-4):120-6. https://doi.org/10.1159/000111873
8) Dham BS, Hunter K, Rincon F, "The epidemiology of status epilepticus in the United States" Neurocrit Care. 2014; 20(3):476-83. https://doi.org/10.1007/s12028-013-9935-x
9) Alvin IC, Max LB, Timothy JM, Martin LY, "Real-time needle steering in response to rolling vein deformation by a 9-dof image-guided autonomous venipuncture robot" J Eme Nurs. 2019; 35:419-24.
10) Fukuda M, Kanazawa T, Iioka S, Oguma T, Iwasa R, Masuoka S, et al., "Quantitative analysis of inulin distribution in the brain focused on nose-to-brain route via olfactory epithelium by reverse esophageal cannulation" J Control Release. 2021; 332:493-501. https://doi.org/10.1016/j.jconrel.2021.02.024
11) Ozgur E, Ayhan S, Cansel KO, Ali O, Berk AG, Mehmet O et al., "Nose to brain delivery of eletriptan hydrobromide nanoparticles: preparation, in vitro/in vivo evaluation and effect on trigeminal activation" J Drug Deliv Sci Technol. 2020; 59. https://doi.org/10.1016/j.jddst.2020.101919
12) Inoue D, Furubayashi T, Tanaka A, Sakane T, Sugano K, "Effect of cerebrospinal fluid circulation on nose-to-brain direct delivery and distribution of caffeine in rats" Mol Pharm. 2020; 17(11):4067-76. https://doi.org/10.1021/acs.molpharmaceut.0c00495
13) Agarwal SK, Cloyd JC, "Development of benzodiazepines for out-of-hospital management of seizure emergencies" Neurol Clin Pract. 2015; 5(1):80-5. https://doi.org/10.1212/CPJ.0000000000000099
14) Maria ECP, Devasish B, Adrià MD, Mayte GA, Josep ER. "Direct injection micellar liquid chromatographic determination of benzodiazepines in serum" J Chem Res B. 2002; 780:241-9. https://doi.org/10.1016/S1570-0232(02)00523-8
15) Rey E, Tréluyer JM, Pons G, "Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes" Clin Pharmacokinet. 1999; 36(6):409-24. https://doi.org/10.2165/00003088-199936060-00003
16) Anderson M, "Benzodiazepines for prolonged seizures" Arch Dis Child Educ Pract Ed. 2010; 95(6):183-9. https://doi.org/10.1136/adc.2009.176321
17) Greenblatt DJ, Divoll M, "Diazepam versus lorazepam: relationship of drug distribution to duration of clinical action" Adv Neurol. 1983; 34:487-91.
18) Kaur P, Kim K, "Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits" Int J Pharm. 2008; 364(1):27-35. https://doi.org/10.1016/j.ijpharm.2008.07.030
19) Charlton ST, Whetstone J, Fayinka ST, Read KD, Illum L, Davis SS, "Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model" Pharm Res. 2008; 25(7):1531-43. https://doi.org/10.1007/s11095-008-9550-2
20) Lüttjohann A, Fabene PF, van Luijtelaar G, "A revised Racine's scale for PTZ-induced seizures in rats" Physiol Behav. 2009; 98(5):579-86. https://doi.org/10.1016/j.physbeh.2009.09.005
21) Kozlovskaya L, Abou-Kaoud M, Stepensky D, "Quantitative analysis of drug delivery to the brain via nasal route" J Control Release. 2014; 189:133-40. https://doi.org/10.1016/j.jconrel.2014.06.053
22) Akita T, Oda Y, Kimura R, Nagai M, Tezuka A, Shimamura M, et al., "Involvement of trigeminal axons in nose-to-brain delivery of glucagon-like peptide-2 derivative" J Control Release. 2022; 351:573-80. https://doi.org/10.1016/j.jconrel.2022.09.047
23) Marek AM, James AF, "Anterior thalamic mediation of generalized pentylenetetrazol seizures" Brain Res. 1986; 399:211-23. https://doi.org/10.1016/0006-8993(86)91511-8
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.